Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) Whether the two comparables, Accentia Technologies Ltd. and Cat Technologies Ltd., were rightly excluded from the transfer pricing set of comparables on the ground of functional dissimilarity and lack of segmental information; (ii) Whether the disallowance under section 14A was required to be confined to a reasonable estimate instead of being computed under Rule 8D for the relevant assessment year; (iii) Whether the addition in respect of loss on sale of fixed assets required fresh verification.
Issue (i): Whether the two comparables, Accentia Technologies Ltd. and Cat Technologies Ltd., were rightly excluded from the transfer pricing set of comparables on the ground of functional dissimilarity and lack of segmental information.
Analysis: Accentia Technologies Ltd. had revenues from medical transcription, coding and software development, but no separate segmental results were available and the accounts reflected a single healthcare segment. The year also involved significant acquisitions, which affected profitability. Cat Technologies Ltd. also derived revenue from multiple activities, with software development and consulting constituting the major share, while medical transcription was only a small part, and no reliable segmental data was available. On these facts, the comparability exercise could not be accepted for either company.
Conclusion: The exclusion of both comparables was and the Revenue's challenge failed.
Issue (ii): Whether the disallowance under section 14A was required to be confined to a reasonable estimate instead of being computed under Rule 8D for the relevant assessment year.
Analysis: The assessment year involved was prior to the applicability of Rule 8D. At the same time, the existence of dividend income and substantial investment in shares showed that some expenditure must have been incurred in relation to exempt income. The disallowance therefore had to be determined on an estimated basis rather than by applying Rule 8D.
Conclusion: The disallowance was restricted to Rs. 30,000 and the assessee succeeded in part.
Issue (iii): Whether the addition in respect of loss on sale of fixed assets required fresh verification.
Analysis: The assessee's plea was that the loss had already been suo motu disallowed and the same amount could not be disallowed again. The proper course was to verify the claim from the record and decide the issue afresh after giving opportunity of hearing.
Conclusion: The matter was remanded for verification and fresh adjudication.
Final Conclusion: The transfer pricing comparables selected by the Revenue were not accepted, the section 14A disallowance was reduced on estimate, and the issue of loss on sale of assets was sent back for reconsideration, resulting in a partial success for the assessee.
Ratio Decidendi: A company cannot be used as a comparable in transfer pricing analysis where reliable segmental results are unavailable and extraordinary events materially affect profitability; and for assessment years prior to Rule 8D, section 14A disallowance must be made on a reasonable estimate rather than by mechanical application of that rule.